ORTC Ortec International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ORTC Ortec International

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: fut_trade who wrote (82)	3/3/1998 2:30:00 AM
From: fut_trade	Read Replies (1) of 272

Here's an article describing Ortec's presentation from last year's American Burn Association meeting. pslgroup.com Composite Cultured Skin May Reduce Hospital Stay for Burn Victims NEW YORK, March 24, 1997 -- The results of a clinical trial of serious burns has shown that composite cultured skin (CCS) technology may offer an exciting treatment option by reducing the length of hospital stays and bypassing autografting. Dr. C. Andrew Salzberg of Westchester County Medical Center Burn Unit presented long-term follow-up data on seven patients with severe burns treated with Ortec International's (Nasdaq: ORTC) Composite Cultured Skin (CCS) at the 29th Annual Meeting of the American Burn Association in New York City....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next